cro.directory
← Compare landing

Fortrea vs Medpace

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/fortrea/medpace

CategoryFortreaMedpace
Listed sitecrocro
SummaryFortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Central Laboratory Services
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Clinical Imaging Core Lab
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Trial Services
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Central Laboratory Services
  • Biomarker Assays
  • Immunogenicity Assays (ADA / NAb)
  • Bioanalysis
  • Clinical Imaging Core Lab
  • Microbiology Services
  • Cardiovascular & Metabolic Specialty Services
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Device & Combination Product Services
  • Japan PMDA Regulatory Strategy
  • CNS Specialty Services
  • Ligand-Binding Bioanalysis (Large Molecule)
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Radiopharmaceutical
Indications
  • Cardiovascular
  • Metabolic
  • Dermatology
  • Infectious Disease
  • Immunology
  • Nephrology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Respiratory
  • Women's Health
  • Gastroenterology
  • Cardiovascular
  • Dermatology
  • Metabolic
  • Gastroenterology
  • Oncology
  • Immunology
  • Infectious Disease
  • Nephrology
  • Neurology
  • Ophthalmology
  • Respiratory
  • Rare Disease
  • Women's Health
Locations
  • Global operations, United States
  • Headquarters, Durham, NC, United States
  • Dallas, Dallas, TX, United States
  • Daytona Beach, Daytona Beach, FL, United States
  • Madison, Madison, WI, United States
  • Sydney, Sydney, NSW, Australia
  • Beijing, Beijing, China
  • Chengdu, Chengdu, Sichuan, China
  • Dalian, Dalian, Liaoning, China
  • Guangzhou, Guangzhou, China
  • Hangzhou, Hangzhou, Zhejiang, China
  • Hong Kong, Hong Kong, China
  • Nanjing, Nanjing, Jiangsu, China
  • Shanghai, Shanghai, China
  • Seoul, Seoul, South Korea
  • Taipei, Taipei, Taiwan
  • Tokyo, Tokyo, Japan
  • Raanana, Raanana, Israel
  • Istanbul, Istanbul, Turkey
  • Bogotá, Bogotá, Colombia
  • Buenos Aires, Buenos Aires, Argentina
  • Lima, Lima, Peru
  • Mexico City, Mexico City, CDMX, Mexico
  • Santiago, Santiago, Chile
  • São Paulo, São Paulo, SP, Brazil
  • Centurion, Centurion, Gauteng, South Africa
  • Clinical Research Unit, Dallas, TX, United States
  • Clinical Research Unit, Daytona Beach, FL, United States
  • Clinical Research Unit, Madison, WI, United States
  • Office, São Paulo, SP, Brazil
  • Office, Mexico City, CDMX, Mexico
  • Office, Buenos Aires, Argentina
  • Office, Santiago, Chile
  • Office, Lima, Peru
  • Office, Bogotá, Colombia
  • Office, Centurion, Gauteng, South Africa
  • Office, Sydney, NSW, Australia
  • Office, Beijing, China
  • Office, Shanghai, China
  • Office, Guangzhou, China
  • Office, Chengdu, Sichuan, China
  • Office, Dalian, Liaoning, China
  • Office, Hangzhou, Zhejiang, China
  • Office, Nanjing, Jiangsu, China
  • Office, Hong Kong, China
  • Office, Tokyo, Japan
  • Office, Seoul, South Korea
  • Office, Taipei, Taiwan
  • Office, Raanana, Israel
  • Office, Istanbul, Turkey
  • Office, Herzliya, Israel
  • Herzliya, Raanana, Israel
  • Herzliya, Herzliya, Israel
  • Office, Hong Kong, Hong Kong
  • Central Laboratories, Cincinnati, Ohio, United States
  • Central Laboratory, Cincinnati, Ohio, United States
  • Headquarters, Cincinnati, OH, USA
  • Dallas, Irving, TX, USA
  • Denver, Denver, CO, USA
  • Mexico City, Mexico City, Distrito Federal, Mexico
  • Leuven, Leuven, Flemish Brabant, Belgium
  • Prague, Prague, Prague, Czech Republic
  • Copenhagen, Copenhagen, Copenhagen, Denmark
  • Lyon, Lyon, Auvergne-Rhône-Alpes, France
  • Munich, Munich, Bavaria, Germany
  • Budapest, Budapest, Budapest, Hungary
  • Rehovot, Rehovot, Central, Israel
  • Milan, Milan, Lombardy, Italy
  • London, London, England, United Kingdom
  • Maastricht, Maastricht, Limburg, Netherlands
  • Rotterdam, Rotterdam, South Holland, Netherlands
  • Warsaw, Warsaw, Masovian, Poland
  • Johannesburg, Johannesburg, Gauteng, South Africa
  • Dallas, Dallas, TX, USA
  • Madrid, Madrid, Spain
  • Mexico, Mexico City, Mexico City, Mexico
Certifications
  • cGMP · Identifier: In-clinic cGMP Pharmacies
  • FDA · Identifier: cGMP
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.